Clinical Trials

The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease

by ClinicalTrialsFeed • 2015/04/16 • 0 Comments

Status: Not yet recruiting, Condition Summary: Thyroid Eye Disease

← Preoperative Tests Still Too Frequent for Cataract Surgery

Study challenges view that sight-based brain sensory network organization is impaired with blindness →